Berggren P, Lachmann B, Curstedt T, Grossmann G, Robertson B
Acta Anaesthesiol Scand. 1986 May;30(4):321-8. doi: 10.1111/j.1399-6576.1986.tb02423.x.
Severe respiratory insufficiency was induced in adult guinea pigs by repeated lung lavage. The animals were then ventilated for 75 min with 100% O2, insufflation pressure 28/6-8 cmH2O (2.7/0.6-0.8 kPa), frequency 30/min, and 33% inspiration time. One group of animals (I) was treated with protein-depleted porcine surfactant, prepared by a combination of sucrose-gradient centrifugation, heating to 90 degrees C, and chloroform/methanol extraction. Another group (II) received the phospholipid fraction of porcine surfactant, isolated from minced lungs by chloroform/methanol extraction and liquid-gel chromatography. Surfactant was administered in two 1-ml doses (lipid concentration 90 mg/ml) instilled via the tracheal cannula about 15 and 45 min after the lavage procedure. Non-treated, lavaged animals served as controls. After 75 min of ventilation, control values for PaO2 and PaCO2 were 13.3 +/- 6.8 and 6.8 +/- 2.3 kPa (mean +/- s.d.), respectively. The corresponding values in Group I of surfactant-treated animals were 52.9 +/- 7.7 and 4.4 +/- 1.1 kPa, in Group II 53.5 +/- 7.3 and 4.8 +/- 1.3 kPa (P less than 0.02-0.002). The two groups of surfactant-treated animals also had significantly improved alveolar air expansion in histological sections, as reflected by increased alveolar volume density (0.67 +/- 0.05 and 0.62 +/- 0.11 vs 0.45 +/- 0.08 in controls; P less than 0.002). The benefits of surfactant replacement in this experimental model were thus similar to those previously observed in animal models of neonatal surfactant deficiency as well as in babies with respiratory distress syndrome (RDS). Our data suggest that surfactant replacement might have a therapeutic effect also in clinical adult RDS.
通过反复肺灌洗在成年豚鼠中诱发严重呼吸功能不全。然后用100%氧气对动物进行通气75分钟,吹入压力28/6 - 8厘米水柱(2.7/0.6 - 0.8千帕),频率30次/分钟,吸气时间33%。一组动物(I组)用通过蔗糖梯度离心、加热至90摄氏度和氯仿/甲醇萃取联合制备的低蛋白猪表面活性剂进行治疗。另一组(II组)接受从切碎的肺中通过氯仿/甲醇萃取和液 - 凝胶色谱分离得到的猪表面活性剂的磷脂部分。在灌洗程序后约15分钟和45分钟,通过气管插管分两次给予1毫升剂量的表面活性剂(脂质浓度90毫克/毫升)。未治疗的灌洗动物作为对照。通气75分钟后,对照组的动脉血氧分压(PaO2)和动脉血二氧化碳分压(PaCO2)值分别为13.3±6.8和6.8±2.3千帕(平均值±标准差)。表面活性剂治疗的I组动物的相应值为52.9±7.7和4.4±1.1千帕,II组为53.5±7.3和4.8±1.3千帕(P < 0.02 - 0.002)。两组表面活性剂治疗的动物在组织学切片中肺泡气扩张也有显著改善,表现为肺泡体积密度增加(分别为0.67±0.05和0.62±0.11,而对照组为0.45±0.08;P < 0.002)。因此,在这个实验模型中表面活性剂替代的益处与先前在新生儿表面活性剂缺乏动物模型以及患有呼吸窘迫综合征(RDS)的婴儿中观察到的益处相似。我们的数据表明,表面活性剂替代在临床成人RDS中可能也有治疗作用。